云南白药：接受广东臻远私募基金等投资者调研

Company Overview - Yunnan Baiyao (SZ 000538) announced that on December 11, 2025, it will accept investor research from Guangdong Zhenyuan Private Equity Fund and others, with company representatives Zhang Yu, Yang Kexin, and Yu Yang participating in the reception and answering investor questions [1] Financial Performance - For the first half of 2025, Yunnan Baiyao's revenue composition is as follows: commercial sales accounted for 59.78%, industrial sales for 40.01%, other businesses for 0.1%, technical development services for 0.08%, and hotel and catering services for 0.03% [1] - As of the report date, Yunnan Baiyao's market capitalization is 99.6 billion yuan [1]